XML 433 R22.htm IDEA: XBRL DOCUMENT v3.22.0.1
PROPERTY, PLANT AND EQUIPMENT
12 Months Ended
Dec. 31, 2021
Property, plant and equipment [abstract]  
PROPERTY, PLANT AND EQUIPMENT
NOTE 15 - PROPERTY, PLANT AND EQUIPMENT
(in millions of Euros)Land and Property RightsBuildingsMachinery and EquipmentConstruction Work in ProgressOtherTotal
Net balance at January 1, 2021203791,361132141,906
Additions6521696233
Disposals(1)(2)(1)(4)
Depreciation expense(1)(27)(210)(3)(12)(253)
Transfer and other changes15153(174)8(7)
Effect of changes in foreign exchange rates11257373
Net balance at December 31, 2021213741,411127151,948
Cost385902,750142573,577
Less accumulated depreciation and impairment(17)(216)(1,339)(15)(42)(1,629)
Net balance at December 31, 2021213741,411127151,948

(in millions of Euros)Land and Property RightsBuildingsMachinery and EquipmentConstruction Work in ProgressOtherTotal
Net balance at January 1, 2020193661,451203172,056
Additions20761293228
Disposals(3)(3)
Depreciation expense(1)(27)(211)(10)(249)
Impairment(6)(28)(8)(42)
Transfer and other changes338139(189)5(4)
Effect of changes in foreign exchange rates(1)(12)(63)(3)(1)(80)
Net balance at December 31, 2020203791,361132141,906
Cost355592,473145483,260
Less accumulated depreciation and impairment(15)(180)(1,112)(13)(34)(1,354)
Net balance at December 31, 2020203791,361132141,906
Right-of-use assets
Right-of-use assets have been included in the same line item as that in which a corresponding owned asset would be presented.
(in millions of Euros)BuildingsMachinery and EquipmentOtherTotal
Net balance at January 1, 2021112722186
Additions5712
Depreciation expense(11)(16)(1)(28)
Transfer and other changes(1)(1)
Effect of changes in foreign exchange rates235
Net balance at December 31, 2021108651174
Cost1501443297
Less accumulated depreciation and impairment(42)(79)(2)(123)
Net balance at December 31, 2021108651174
(in millions of Euros)BuildingsMachinery and EquipmentOtherTotal
Net balance at January 1, 2020116713190
Additions1933153
Disposals(1)(1)
Depreciation expense(12)(22)(2)(36)
Impairment(4)(5)(9)
Transfer and other changes(4)(1)(5)
Effect of changes in foreign exchange rates(3)(3)(6)
Net balance at December 31, 2020112722186
Cost1421354281
Less accumulated depreciation and impairment(30)(63)(2)(95)
Net balance at December 31, 2020112722186
The total expense relating to short-term leases, low value asset leases and variable lease payments that are still recognized as operating expenses was €12 million and €11 million for the years ended December 31, 2021 and December 31, 2020, respectively.
Depreciation expense
Total depreciation expense relating to property, plant and equipment and intangible assets are presented in the Consolidated Income Statement as follows:
Year ended December 31,
(in millions of Euros)202120202019
Cost of sales(245)(240)(237)
Selling and administrative expenses(17)(14)(13)
Research and development expenses(5)(5)(6)
Total depreciation expense(267)(259)(256)
The amount of contractual commitments for the acquisition of property, plant and equipment is disclosed in NOTE 27 - Commitments.
Impairment tests for property, plant and equipment and intangibles assets
No triggering events were identified at December 31, 2021 for our CGUs.
At December 31, 2020, the downturn in the aerospace industry resulting from the COVID-19 pandemic was identified as an indicator of impairment for all the Cash Generating Units (“CGUs”) in the A&T segment.
As a result, these CGUs were tested for impairment and their value in use was calculated using discounted cash flows based on a financial forecast for the period 2021-2025 prepared by management and reflecting the following key assumptions:
Aerospace market demand was expected to be down by approximately 50% in 2021 and 2022 compared to 2019,
Reductions in costs and capital expenditures were assumed to help partially offset weak demand,
Profitability and cash-flows were assumed to recover in the 2023 to 2025 period, but remained below 2019 levels,
The terminal value was determined using a perpetuity growth calculation assuming a long term growth rate of 1.5%,
A discount rate of 9% was assumed.
This impairment test conclusion to fully impair two CGUs for €16 million (€9 million for the Montreuil-Juigné plant and €7 million for the Ussel plant) was reached in the year ended December 31, 2020.
The Group also tested the sensitivity of two other A&T CGUs to changes in cash flows, in discount rates, and in perpetuity growth rates:
With cash-flows that were 20% lower from 2021 to 2025, including the terminal year cash flow, the recoverable value would exceed the carrying value for one CGU, and equal the carrying value for the other CGU,
With an increase in the discount of 275 basis points, the recoverable value of one CGU would exceed the carrying value, and equal the carrying value for the other CGU,
With a decrease in the perpetual growth rate of 400 basis points, the recoverable value of one CGU would exceed the carrying value, and equal the carrying value for the other CGU.
At December 31, 2020, management also reviewed the CGUs in the AS&I segment and identified an indicator of impairment for two Automotive Structures plants - Nanjing, China and White, Georgia, U.S.
In June 2020, one of the main customers of the Nanjing plant announced a suspension of its operations as well as a strategic reorganization and the business prospects were reviewed consequently. The White Georgia plant was tested for impairment due to lower profitability than expected as a result of operational challenges faced in the implementation of a new technology developed for one specific automotive platform leading management to reassess the long-term prospects of the plant.
As a result, these two CGUs were tested for impairment and their values in use were calculated using discounted cash flows and a discount rate of 9%. Based on this analysis the conclusion to fully impair the Nanjing plant for €12 million was reached in the year ended December 31, 2020. The White Georgia plant was partially impaired for €13 million, leading to a carrying value of €11 million at December 31, 2020.
There were no other impairment indicators identified for our other CGUs at December 31, 2020.
At December 31, 2019, a triggering event was identified for the Automotive Structure USA CGUs due to the fact that actual operating profit and net cash flows were impacted by higher than expected costs related to operational challenges on some of the newer automotive programs. The Automotive Structure USA CGUs were tested for impairment at December 31, 2019 and management concluded that no impairment charge was required. No triggering events were identified at December 31, 2019 for our other CGUs.